找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Biological Response Modifiers in Human Oncology and Immunology; Thomas Klein,Steven Specter,Andor Szentivanyi Book 1983 The Editor(s) (if

[復(fù)制鏈接]
查看: 35186|回復(fù): 66
樓主
發(fā)表于 2025-3-21 16:07:14 | 只看該作者 |倒序瀏覽 |閱讀模式
期刊全稱Biological Response Modifiers in Human Oncology and Immunology
影響因子2023Thomas Klein,Steven Specter,Andor Szentivanyi
視頻videohttp://file.papertrans.cn/188/187452/187452.mp4
學科分類Advances in Experimental Medicine and Biology
圖書封面Titlebook: Biological Response Modifiers in Human Oncology and Immunology;  Thomas Klein,Steven Specter,Andor Szentivanyi Book 1983 The Editor(s) (if
影響因子The topic of biological response modifiers has attracted the attention of many biomedical investigators, including immunologists, oncologists, pharmacologists, microbiologists, and biochemists, as well as clinical practitioners of medicine. This has occurred mainly because of the realization that the complex system of cellular and humoral interactions culminating in a productive immune response is under exquisite regulatory control for normal immune responses and that loss of control may markedly influence the capability of a host to respond in a productive manner to the numerous immunologic "insults" encountered in the environment. Furthermore, biological response modification is considered by many to be a natural offshoot of the relatively new application of "immunotherapy" to cancer. It is widely recognized that "immunotherapy" was practiced at the end of the last century and the beginning of this century when it was recognized that microbial infections were caused by distinct species of bacteria and that passive administration of serum con- taining antibody to these microbes or their products could, in many cases, favorably influence the outcome of an infectious process.
Pindex Book 1983
The information of publication is updating

書目名稱Biological Response Modifiers in Human Oncology and Immunology影響因子(影響力)




書目名稱Biological Response Modifiers in Human Oncology and Immunology影響因子(影響力)學科排名




書目名稱Biological Response Modifiers in Human Oncology and Immunology網(wǎng)絡(luò)公開度




書目名稱Biological Response Modifiers in Human Oncology and Immunology網(wǎng)絡(luò)公開度學科排名




書目名稱Biological Response Modifiers in Human Oncology and Immunology被引頻次




書目名稱Biological Response Modifiers in Human Oncology and Immunology被引頻次學科排名




書目名稱Biological Response Modifiers in Human Oncology and Immunology年度引用




書目名稱Biological Response Modifiers in Human Oncology and Immunology年度引用學科排名




書目名稱Biological Response Modifiers in Human Oncology and Immunology讀者反饋




書目名稱Biological Response Modifiers in Human Oncology and Immunology讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:22:01 | 只看該作者
Interferon Hybrids: Prospects for Therapyn free from other species and other proteins simultaneously induced in human cell cultures. Comparison of the properties of different molecular species of interferon and molecular hybrids between the various species has indicated the extent to which the various biological properties of interferons m
板凳
發(fā)表于 2025-3-22 03:19:34 | 只看該作者
地板
發(fā)表于 2025-3-22 08:37:51 | 只看該作者
Monoclonal Antibodies as Anticancer Agentsat the therapeutic/toxic ratio is low for anticancer drugs and for radiation therapy. A major advance in the treatment of cancer could be heralded by the development of a class of agents that have a greater degree of specificity for the tumor cell. The technique of hybridization of an immortal myelo
5#
發(fā)表于 2025-3-22 10:43:07 | 只看該作者
Treatment of a Murine Leukemia with Chlorambucil Bound Monoclonal Antibodiesmors, its utility has been limited due to toxicity to normal cells (2–3). Recent advances in experimental immunobiology, tumor immunology and cancer metastasis have increased our knowledge concerning the host’s immune response to tumors and the regulation of tumor growth (4–5). These advances have a
6#
發(fā)表于 2025-3-22 14:47:22 | 只看該作者
Immune Response in Strain 2 Guinea Pigs to the Syngeneic L2C Leukemianoglobulin (Ig) and complement receptors on the surface of L2C tumor cells has established the B lymphocyte lineage of this leukemia (2). Five closely related mutant sublines of the L2C leukemia have been described (3) and are presumed to be derived from the same stem cell on the basis of cytogeneic
7#
發(fā)表于 2025-3-22 20:03:03 | 只看該作者
8#
發(fā)表于 2025-3-23 00:38:42 | 只看該作者
Protective Activity of Thymosin α1 Against Tumor Progression in Immunosuppressed Mice the thymic hormones, thymosin (1), stimulates T cell development and corrects some immunodeficiency diseases resulting from lack of thymus functions. Considering the importance of T cells in immunoregulatory systems, thymosin is expected to be useful as a pharmaceutical agent for a variety of disea
9#
發(fā)表于 2025-3-23 02:36:24 | 只看該作者
Effect of Thymostimulin on Human Lymphocyte Adenosine Deaminase and Purine Nucleoside Phosphorylase m calf thymus and has been used in the treatment of primary and secondary immunodeficiencies (1, 2). However, the immunobiological properties and the mechanism of action of this cellular extract is still not completely understood. For this reason, we have studied the activity of thymostimulin on the
10#
發(fā)表于 2025-3-23 06:20:05 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 09:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
金华市| 铁岭市| 唐海县| 巨鹿县| 吉安市| 类乌齐县| 普洱| 宁安市| 清远市| 大邑县| 淮滨县| 东安县| 莒南县| 霞浦县| 扬中市| 辽宁省| 武威市| 那曲县| 汝州市| 新宁县| 涿鹿县| 赫章县| 秭归县| 夏津县| 娄烦县| 汉寿县| 黔南| 平顶山市| 平乡县| 肇东市| 田阳县| 杂多县| 延吉市| 张掖市| 游戏| 和林格尔县| 泸水县| 山阴县| 长春市| 栖霞市| 德格县|